240 related articles for article (PubMed ID: 29222126)
21. Amphiphysin autoimmunity: paraneoplastic accompaniments.
Pittock SJ; Lucchinetti CF; Parisi JE; Benarroch EE; Mokri B; Stephan CL; Kim KK; Kilimann MW; Lennon VA
Ann Neurol; 2005 Jul; 58(1):96-107. PubMed ID: 15984030
[TBL] [Abstract][Full Text] [Related]
22. Seizure characteristics and outcomes in patients with neurological conditions related to high-risk paraneoplastic antibodies.
Smith KM; Britton JW; Thakolwiboon S; Chia NH; Gupta P; Flanagan EP; Zekeridou A; Lopez Chiriboga AS; Valencia Sanchez C; McKeon A; Pittock SJ; Dubey D
Epilepsia; 2023 Sep; 64(9):2385-2398. PubMed ID: 37366270
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune chorea in adults.
O'Toole O; Lennon VA; Ahlskog JE; Matsumoto JY; Pittock SJ; Bower J; Fealey R; Lachance DH; McKeon A
Neurology; 2013 Mar; 80(12):1133-44. PubMed ID: 23427325
[TBL] [Abstract][Full Text] [Related]
24. Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients.
Iorio R; Damato V; Evoli A; Gessi M; Gaudino S; Di Lazzaro V; Spagni G; Sluijs JA; Hol EM
J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):138-146. PubMed ID: 28951498
[TBL] [Abstract][Full Text] [Related]
25. Contactin-1 autoimmunity: Serologic, neurologic, and pathologic correlates.
Dubey D; Honorat JA; Shelly S; Klein CJ; Komorowski L; Mills JR; Brakopp S; Probst C; Lennon VA; Pittock SJ; McKeon A
Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32461352
[TBL] [Abstract][Full Text] [Related]
26. Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin G.
Keegan BM; Pittock SJ; Lennon VA
Ann Neurol; 2008 Apr; 63(4):531-4. PubMed ID: 18306241
[TBL] [Abstract][Full Text] [Related]
27. Microtubule-associated protein 1B: Novel paraneoplastic biomarker.
Gadoth A; Kryzer TJ; Fryer J; McKeon A; Lennon VA; Pittock SJ
Ann Neurol; 2017 Feb; 81(2):266-277. PubMed ID: 28074593
[TBL] [Abstract][Full Text] [Related]
28. Antibodies and neuronal autoimmune disorders of the CNS.
Graus F; Saiz A; Dalmau J
J Neurol; 2010 Apr; 257(4):509-17. PubMed ID: 20035430
[TBL] [Abstract][Full Text] [Related]
29. Paraneoplastic autoimmunity and small-cell lung cancer: Neurological and serological accompaniments.
Zekeridou A; Majed M; Heliopoulos I; Lennon VA
Thorac Cancer; 2019 Apr; 10(4):1001-1004. PubMed ID: 30810271
[TBL] [Abstract][Full Text] [Related]
30. CV2/CRMP5-antibody-related Paraneoplastic Optic Neuropathy Associated with Small-cell Lung Cancer.
Nakajima M; Uchibori A; Ogawa Y; Miyazaki T; Ichikawa Y; Kaneko K; Takahashi T; Nakashima I; Shiraishi H; Motomura M; Chiba A
Intern Med; 2018 Jun; 57(11):1645-1649. PubMed ID: 29321433
[TBL] [Abstract][Full Text] [Related]
31. Paraneoplastic neuropathies and peripheral nerve hyperexcitability disorders.
Shelly S; Dubey D; Mills JR; Klein CJ
Handb Clin Neurol; 2024; 200():239-273. PubMed ID: 38494281
[TBL] [Abstract][Full Text] [Related]
32. CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling.
Moutal A; Honnorat J; Massoma P; Désormeaux P; Bertrand C; Malleval C; Watrin C; Chounlamountri N; Mayeur ME; Besançon R; Naudet N; Magadoux L; Khanna R; Ducray F; Meyronet D; Thomasset N
Cancer Res; 2015 Sep; 75(17):3519-28. PubMed ID: 26122847
[TBL] [Abstract][Full Text] [Related]
33. Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments.
Pittock SJ; Lucchinetti CF; Lennon VA
Ann Neurol; 2003 May; 53(5):580-7. PubMed ID: 12730991
[TBL] [Abstract][Full Text] [Related]
34. Mechanism, and treatment of anti-CV2/CRMP5 autoimmune pain.
Martin L; Stratton HJ; Gomez K; Le Duy D; Loya-Lopez S; Tang C; Calderon-Rivera A; Ran D; Nunna V; Bellampalli SS; François-Moutal L; Dumaire N; Salih L; Luo S; Porreca F; Ibrahim M; Rogemond V; Honnorat J; Khanna R; Moutal A
bioRxiv; 2024 May; ():. PubMed ID: 38766071
[TBL] [Abstract][Full Text] [Related]
35. Autonomic dysfunction in peripheral nerve disease.
Low PA; Vernino S; Suarez G
Muscle Nerve; 2003 Jun; 27(6):646-61. PubMed ID: 12766975
[TBL] [Abstract][Full Text] [Related]
36. Aquaporin-4 autoantibodies in a paraneoplastic context.
Pittock SJ; Lennon VA
Arch Neurol; 2008 May; 65(5):629-32. PubMed ID: 18474738
[TBL] [Abstract][Full Text] [Related]
37. Autoimmune peripheral neuropathies.
Bourque PR; Chardon JW; Massie R
Clin Chim Acta; 2015 Sep; 449():37-42. PubMed ID: 25748038
[TBL] [Abstract][Full Text] [Related]
38. Autoimmune/Paraneoplastic Encephalitis Antibody Biomarkers: Frequency, Age, and Sex Associations.
Kunchok A; McKeon A; Zekeridou A; Flanagan EP; Dubey D; Lennon VA; Klein CJ; Mills JR; Pittock SJ
Mayo Clin Proc; 2022 Mar; 97(3):547-559. PubMed ID: 34955239
[TBL] [Abstract][Full Text] [Related]
39. Rapidly progressive neurological deterioration in anti-AMPA receptor encephalitis with additional CRMP5 antibodies.
Yang S; Qin J; Li J; Gao Y; Zhao L; Wu J; Song B; Xu Y; Sun S
Neurol Sci; 2016 Nov; 37(11):1853-1855. PubMed ID: 27465029
[TBL] [Abstract][Full Text] [Related]
40. The collapsin response mediator protein 5 onconeural protein is expressed in Schwann cells under axonal signals and regulates axon-Schwann cell interactions.
Camdessanché JP; Ferraud K; Boutahar N; Lassablière F; Mutter M; Touret M; Kolattukudy P; Honnorat J; Antoine JC
J Neuropathol Exp Neurol; 2012 Apr; 71(4):298-311. PubMed ID: 22437341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
